Key Takeaways
- • Private equity firms have gained increasing control of U.S. health care infrastructure, fundamentally transforming the operational and financial structure of American medicine as documented in a March 2026 *New England Journal of Medicine* Perspective.
- • While PE investors claim operational improvements, capital access, and economies of scale, evidence shows their involvement frequently results in reduced access to affordable, high-quality care for vulnerable populations including rural communities, elderly patients, low-income groups, and marginalized racial and ethnic populations.
- • PE-backed health care entities have extracted excessively high financial returns at the expense of patient access and clinician burden, disproportionately harming populations already struggling with affordability and health system navigation.
- • States can mitigate PE-driven health care degradation through regulatory monitoring of operational and accounting practices, with enforcement mechanisms targeting entities that compromise access to affordable, high-quality care.
- • Without strong regulation and enforcement, PE transformation of health care infrastructure poses systemic risks to health equity and threatens to entrench existing disparities in care access across demographic groups.
Summary
Private equity firms have significantly expanded their control over U.S. health care infrastructure, raising substantive concerns about health equity and access to care. According to research published in the *New England Journal of Medicine* Perspective (Volume 394, Issue 10, March 5, 2026), authored by Ruqaiijah Yearby of Temple University's Beasley School of Law and Marcella Alsan of Stanford University's School of Humanities and Sciences, PE involvement in health care presents systemic risks to vulnerable populations.
PE investors have justified their health care investments by citing improved operational efficiency, enhanced capital access for under-resourced systems, and leveraged economies of scale. However, empirical evidence contradicts these claims. Research demonstrates that PE operational models frequently prioritize financial extraction over patient outcomes, resulting in diminished access to affordable and high-quality care. As Alsan notes, "Although PE has extended financing to under-resourced health care systems and generated profits for partners, it has done so at a steep price."
The burden of PE health care transformation has fallen disproportionately on specific populations. Evidence shows that excessively high PE returns consistently come at the expense of rural populations, elderly patients, low-income communities, and members of marginalized racial and ethnic groups—demographics already experiencing significant barriers to care affordability and health system navigation. This pattern intensifies existing health inequities rather than ameliorating them.
The research identifies state-level regulatory intervention as a critical mitigation strategy. Policymakers can establish monitoring mechanisms to track PE operational and accounting practices within health care entities, coupled with enforcement authority to penalize organizations that compromise access to affordable, high-quality care. Without such regulatory frameworks and active enforcement, PE practices are likely to continue reshaping American health care in ways that fundamentally harm patients and increase burden on clinical practitioners, further stratifying health outcomes by socioeconomic and demographic status.
PE investors have justified their health care investments by citing improved operational efficiency, enhanced capital access for under-resourced systems, and leveraged economies of scale. However, empirical evidence contradicts these claims. Research demonstrates that PE operational models frequently prioritize financial extraction over patient outcomes, resulting in diminished access to affordable and high-quality care. As Alsan notes, "Although PE has extended financing to under-resourced health care systems and generated profits for partners, it has done so at a steep price."
The burden of PE health care transformation has fallen disproportionately on specific populations. Evidence shows that excessively high PE returns consistently come at the expense of rural populations, elderly patients, low-income communities, and members of marginalized racial and ethnic groups—demographics already experiencing significant barriers to care affordability and health system navigation. This pattern intensifies existing health inequities rather than ameliorating them.
The research identifies state-level regulatory intervention as a critical mitigation strategy. Policymakers can establish monitoring mechanisms to track PE operational and accounting practices within health care entities, coupled with enforcement authority to penalize organizations that compromise access to affordable, high-quality care. Without such regulatory frameworks and active enforcement, PE practices are likely to continue reshaping American health care in ways that fundamentally harm patients and increase burden on clinical practitioners, further stratifying health outcomes by socioeconomic and demographic status.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.